These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2886929)

  • 1. [The maintenance dosage of neuroleptic agents].
    Stolk PJ
    Ned Tijdschr Geneeskd; 1987 Jul; 131(27):1158-9. PubMed ID: 2886929
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-induced emesis: a new indication for clozapine?
    Bustillo JR; Buchanan RW
    Biol Psychiatry; 1995 Aug; 38(3):194-5. PubMed ID: 7578665
    [No Abstract]   [Full Text] [Related]  

  • 3. High and very high dosage antipsychotics: a critical review.
    Aubree JC; Lader MH
    J Clin Psychiatry; 1980 Oct; 41(10):341-50. PubMed ID: 6107290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 6. ICI 204,636: a new atypical antipsychotic drug.
    Hirsch SR; Link CG; Goldstein JM; Arvanitis LA
    Br J Psychiatry Suppl; 1996 May; (29):45-56. PubMed ID: 8733823
    [No Abstract]   [Full Text] [Related]  

  • 7. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 8. Typical neuroleptics and increased subcortical volumes.
    Dean CE
    Am J Psychiatry; 1999 Nov; 156(11):1843-4. PubMed ID: 10553769
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to the problem of preventing hazards of long-term neuroleptic treatment and of avoiding unnecessary drugs.
    Kristjansen P
    Adv Biochem Psychopharmacol; 1980; 24():505-11. PubMed ID: 6105796
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug treatment of schizophrenia.
    Hollister LE
    Psychiatr Clin North Am; 1984 Sep; 7(3):435-52. PubMed ID: 6148741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do atypical antipsychotic agents cause tardive dyskinesia?
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2004 Oct; 42(10):14-9. PubMed ID: 15540874
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use and value of the therapeutic neuroleptic-bromocriptine combination in schizophrenia].
    Lombertie ER; Durelle G; Fuseau A
    Ann Med Psychol (Paris); 1995 Oct; 153(8):531-4. PubMed ID: 8561400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
    Costentin J
    Encephale; 2009 Jan; Suppl 3():S119-22. PubMed ID: 19268181
    [No Abstract]   [Full Text] [Related]  

  • 14. Prediction of outcome in first-episode schizophrenia.
    Lieberman JA
    J Clin Psychiatry; 1993 Mar; 54 Suppl():13-7. PubMed ID: 8097192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fluspirilene--safe weekly tranquilizer?].
    Kuhn W; Wöhrle M; Müller T; Welter F
    Nervenarzt; 1997 Jun; 68(6):528. PubMed ID: 9312689
    [No Abstract]   [Full Text] [Related]  

  • 16. Tardive and chronically recurrent oculogyric crises.
    Sachdev P
    Mov Disord; 1993; 8(1):93-7. PubMed ID: 8093550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neuroleptic-related admissions to a university psychiatric clinic].
    Schmidt LG; Langscheid-Schmidt K
    Nervenarzt; 1987 Jun; 58(6):379-82. PubMed ID: 2886932
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of tardive dyskinesia caused by neuroleptic therapy].
    Perényi A
    Orv Hetil; 1981 Jul; 122(27):1627-30. PubMed ID: 6117046
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic-induced movement disorders - forgotten but not gone.
    Weiden PJ
    Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.